{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:32:12Z","timestamp":1792085532505,"version":"4.4.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Congenital hyperinsulinism [CHI] is a rare disorder characterised by hypoglycaemia secondary to excessive insulin secretion from the pancreas. The aim of management of CHI is to prevent severe and persistent hypoglycaemia which can lead to poor neurodevelopmental outcomes. Pancreatic surgery can play a role in the improvement of glycaemic safety in focal and diffuse CHI. Continuous glucose monitoring [CGM] is increasingly used in diabetes management, yet its application in CHI, particularly during perioperative settings, remains underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the utility and accuracy of CGM during pancreatic surgery in CHI patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>A mixed methods observational study was conducted over three years involving 13 patients undergoing either focal lesionectomy or subtotal pancreatectomy. CGM was performed using the Dexcom G6 device, paired with point-of-care capillary blood glucose measurements to assess accuracy. Qualitative feedback from healthcare professionals and quantitative analysis of CGM data were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hyperglycaemia was observed in 8 patients, influenced by surgical stress and dextrose administration. CGM analysis revealed a median perioperative glucose level of 9.2 mmol\/L, with a mean absolute relative difference [MARD] of 19.3% compared to capillary samples. The majority of professionals [94%] reported CGM as helpful in the perioperative period, highlighting its role in guiding prompt adjustment of dextrose infusions and reducing blood sampling frequency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CGM demonstrates utility in monitoring glycaemic trends and managing hyperglycaemia during pancreatic surgery in CHI patients. The integration into perioperative care may further enhance surgical safety, extending the range of clinical applications of CGM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1788026","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:36:16Z","timestamp":1773207376000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Utility of continuous glucose monitoring during pancreatic surgery in patients with congenital hyperinsulinism"],"prefix":"10.3389","volume":"17","author":[{"given":"Sarah","family":"Worthington","sequence":"first","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital","place":["Manchester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Worth","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital","place":["Manchester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera","family":"Auckburally","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital","place":["Manchester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bowler","sequence":"additional","affiliation":[{"name":"Department of Paediatric Anaesthesia, Royal Manchester Children\u2019s Hospital","place":["Manchester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Beauve","sequence":"additional","affiliation":[{"name":"Department of Paediatric Anaesthesia, Royal Manchester Children\u2019s Hospital","place":["Manchester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"O\u2019Shea","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital","place":["Manchester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross\u00a0J","family":"Craigie","sequence":"additional","affiliation":[{"name":"Department of Paediatric Surgery, Royal Manchester Children\u2019s Hospital","place":["Manchester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Salomon-Estebanez","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital","place":["Manchester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indraneel","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital","place":["Manchester, United Kingdom"]},{"name":"Faculty of Biology, Medicine and Health, University of Manchester","place":["Manchester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228417","article-title":"Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389","volume":"15","author":"Yau","year":"2020","journal-title":"PloS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1177\/19322968241245923","article-title":"First accuracy and user-experience evaluation of new continuous glucose monitoring system for hypoglycemia due to hyperinsulinism","volume":"19","author":"Worth","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2539","article-title":"High risk of diabetes and neurobehavioral deficits in individuals with surgically treated hyperinsulinism","volume":"100","author":"Lord","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14152","article-title":"Complexities in the medical management of hypoglycaemia due to congenital hyperinsulinism","volume":"92","author":"Worth","year":"2020","journal-title":"Clin Endocrinology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0673","article-title":"Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism","volume":"168","author":"Kapoor","year":"2013","journal-title":"Eur J Endocrinology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/19322968241245923","article-title":"Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia","volume":"36","author":"Banerjee","year":"2018","journal-title":"Diabetic Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1750-1172-6-63","article-title":"Congenital hyperinsulinism: current trends in diagnosis and therapy","volume":"6","author":"Arnoux","year":"2011","journal-title":"Orphanet J Rare Diseases"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1089\/dia.2015.0417","article-title":"Continuous glucose monitoring: A review of successes, challenges, and opportunities","volume":"18","author":"Rodbard","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/pedi.13029","article-title":"Continuous glucose monitoring for hypoglycaemia in children: Perspectives in 2020","volume":"21","author":"Worth","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1116864","article-title":"Continuous glucose monitoring for children with hypoglycaemia: Evidence in 2023","volume":"14","author":"Worth","year":"2023","journal-title":"Front Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1016072","article-title":"The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism","volume":"13","author":"Worth","year":"2022","journal-title":"Front Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1265076","article-title":"Accuracy and impact on quality of life of real-time continuous glucose monitoring in children with hyperinsulinaemic hypoglycaemia","volume":"14","author":"Sivasubramanian","year":"2023","journal-title":"Front Endocrinology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/20552076221129712","article-title":"HYPO-CHEAT\u2019s aggregated weekly visualisations of risk reduce real world hypoglycaemia","volume":"8","author":"Worth","year":"2022","journal-title":"Digital Health"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.894559","article-title":"Families\u2019 Experiences of continuous glucose monitoring in the management of congenital hyperinsulinism: A thematic analysis","volume":"13","author":"Auckburally","year":"2022","journal-title":"Front Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13446","article-title":"ISPAD clinical practice consensus guidelines 2022: Management of children and adolescents with diabetes requiring surgery","volume":"23","author":"Kapellen","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2856","article-title":"Accuracy of dexcom G6 continuous glucose monitoring in non\u2013critically ill hospitalized patients with diabetes","volume":"44","author":"Davis","year":"2021","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/19322968241255842","article-title":"Continuous glucose monitoring\u2013derived glycemic phenotyping of childhood hypoglycemia due to hyperinsulinism: A year-long prospective nationwide observational study","volume":"19","author":"Worth","year":"2024","journal-title":"J Diabetes Sci Technology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1788026\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:36:17Z","timestamp":1773207377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1788026\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":17,"alternative-id":["10.3389\/fendo.2026.1788026"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1788026","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1788026"}}